SNP rs356219 of the α-synuclein (SNCA) gene is associated with Parkinson's disease in a Chinese Han population

Parkinsonism and Related Disorders

Volumn 18, Issue 5, 2012, Pages 632-634

  Pan, Fenghua ^a,b   Dong, Hairong ^a   Ding, Haixia ^a   Ye, Min ^c   Liu, Weiguo ^d   Wu, Yanfeng ^b   Zhang, Xueling ^e   Chen, Zhuoyou ^f   Luo, Yang ^g   Ding, Xinsheng ^a,c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e Suqian People's Hospital   (China)

^f THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^g YiZheng People's Hospital   (China)

Author keywords

Alpha synuclein; Parkinson's disease; Polymorphism

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ALPHA SYNUCLEIN GENE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HOMOZYGOSITY; HUMAN; LIGASE DETECTION REACTION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; ALPHA-SYNUCLEIN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 84862820839     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.01.025     Document Type: Article

References (14)

1. Zhang Z.X., Roman G.C., Hong Z., Wu C.B., Qu Q.M., Huang J.B., et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 2005, 365(9459):595-597.
2. Huang Y., Cheung L., Rowe D., Halliday G. Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 2004, 46(1):44-70.
3. Mollenhauer B., Locascio J.J., Schulz-Schaeffer W., Sixel-Doring F., Trenkwalder C., Schlossmacher M.G. Alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with Parkinsonism: a cohort study. Lancet Neurol 2011, 10(3):230-240.
4. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K.J., Wolf B., et al. Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain. The FASEB Journal 2008, 22(5):1327-1334.
5. The UK Parkinson's Disease Consortium and The Wellcome Trust Case Control Consortium 2 Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011, 20(22):345-353.
6. Yu L., Xu P., He X., Hu F., Lin Z., Zhu M., et al. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population. Brain Research 2010, 1346:262-265.
7. Elbaz A., Ross O.A., Ioannidis J.P., Soto-ortolaza A.L., Moisan F., Aasly J., et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 2011, 69(5):778-792.
8. Wider C., Vilarino-Guell C., Heckman M.G., Jasinska-Myga B., Ortolaza-Soto A.I., Diehl N.N., et al. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. Eur J Neurol 2011, 18(6):876-881.
9. Refenes N., Kreutz R., Bolbrinker J., Tagaris G., Orlacchio A., Drakoulis N. Non-replication of association between MAPT-SNCA synergistical interaction and susceptibility to Parkinson's disease in a southern European population. Review of Clinical Pharmacology and Pharmacokinetics 2010, 24(2):205-207. English Edition.
10. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992, 32(Suppl):S125-S127.
11. Tan E.K., Chai A., Teo Y.Y., Zhao Y., Tan C., Shen H., et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. Neurology 2004, 62(1):128-131.
12. Hu F., Hu W., Liu L., Yu L., Xi J., He X., et al. Lack of replication of a previously reported association between polymorphism in the 3_UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects. Neuroscience Letters 2010, 479:31-33.
13. Mata I.F., Shi M., Agarwal P., Chunq K.A., Edwards K.L., Factor S.A., et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol 2010, 67(11):1350-1356.
14. Westerlund M., Belin A.C., Anvret A., Hakansson A., Nissbrandt H., Lind C., et al. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. The FASEB Journal 2008, 22(10):3509-3514.